 The tranSMART platform has been adopted and evaluated by numerous pharmaceutical companies, not-for-profits and patient advocacy groups, academics, governmental organisations and service providers.At the Bio-IT World industry conference both the Innovative Medicines Initiative's U-BIOPRED project and The Michael J.Fox Foundation were awarded a Best Practices Award for their application of the platform.